Position in GILD
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$15,989,590
+$3,267,897 QoQ
Shares Held
126,560
+38.7% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#358
of 2,266 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAYDEN & RYGEL holds $102,478,534 across 7 Drug Manufacturers - General names. GILD ranks #5 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
200,960 | $25,823,360 | |
| 2 | ABBV |
AbbVie Inc.
|
73,250 | $18,432,630 | |
| 3 | LLY |
ELI LILLY & Co
|
14,670 | $17,595,639 | |
| 4 | JNJ |
Johnson & Johnson
|
64,900 | $16,482,653 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
126,560 | $15,989,590 | |
| 6 | PFE |
Pfizer Inc
|
311,580 | $7,502,846 | |
| 7 | AMGN |
Amgen Inc
|
1,800 | $651,816 |
All Filings in GILD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,989,590 | 126,560 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $12,721,693 | 91,280 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $11,203,707 | 91,280 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $10,132,080 | 91,280 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $7,581,290 | 68,380 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $20,169 | 180 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,626 | 180 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,091 | 180 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $12,349 | 180 | Shares | Sole | 2024-10-07 | |
| 2024-03-31 | $196,310 | 2,680 | Shares | Sole | 2024-10-08 | |
| 2023-12-31 | $217,106 | 2,680 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $200,839 | 2,680 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $206,547 | 2,680 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $945,858 | 11,400 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $978,690 | 11,400 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $703,266 | 11,400 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $704,634 | 11,400 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $677,730 | 11,400 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $21,906,437 | 301,700 | Shares | Sole | 2022-02-11 | |
| 2020-12-31 | $81,564 | 1,400 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $88,466 | 1,400 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,600,352 | 20,800 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $1,555,008 | 20,800 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||